2170 — Suzhou Basecare Medical Cashflow Statement
0.000.00%
Last trade - 00:00- HK$549.79m
- -HK$166.42m
- CNY207.98m
Annual cashflow statement for Suzhou Basecare Medical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -531 | -882 | -126 | — | — |
| Depreciation | |||||
| Non-Cash Items | 515 | 833 | 1.27 | — | — |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -31 | -22.2 | -79 | -189 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -38.1 | -64.3 | -198 | -189 | — |
| Capital Expenditures | -2.36 | -8.09 | -36.9 | -129 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 19.1 | 41.6 | -19.7 | 40.1 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 16.8 | 33.5 | -56.6 | -88.7 | — |
| Financing Cash Flow Items | -1.3 | -17.5 | -93.7 | -3.08 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 26.5 | 207 | 1,596 | 23.5 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.11 | 168 | 1,331 | -191 | — |